Trials / Completed
CompletedNCT05729971
Nasogastric Tube After Laparoscopic Heller-Dor Myotomy
Nasogastric Tube After Laparoscopic Heller-Dor Myotomy: do You Really Need it?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- Federico II University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this prospective observational study is to evaluate the role of nasogastric tube (NGT) in patients with achalasia underwent to Heller-Dor laparoscopic. The main question it aims to answer are: • If it is possible to remove NGT at the end of surgery. Participants will be dived in two groups: the first one with NGT after surgery and second one without NGT (noNGT). If there is a comparison group: Researchers will compare group NGT and group noNGT to see if routine placement of NGT is useless.
Detailed description
Achalasia is a rare disease characterized by dysfunction of low oesophageal sphincter. This disease is divided according to Chicago classification into three subtypes. Laparoscopic Heller - Dor is a important treatment of types I and II Achalasia. There are several studies evaluating the NGT in colorectal, hepatic, urologic, thoracic, otorhinolaryngology, gastric and esophageal surgery. Its use in postoperative period in achalasic patients is not yet clear. Historically, NGT has been used to reduce gastric distention, nausea, vomiting and chest pain. The aim of our study is to value the role of NGT for this surgery. We prospectively enrolled achalasic patients undergoing laparoscopic Heller -Dor . The NGT group and noNGT were compared in terms of perioperative outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | nasogastric tube | The intervention consists in removing or not the nasogastric tube at the end of the surgery. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2022-07-30
- Completion
- 2022-11-30
- First posted
- 2023-02-15
- Last updated
- 2023-02-15
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05729971. Inclusion in this directory is not an endorsement.